Adults 18 to 60, female only, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Stress-induced Overeating Measured Via Smartphone SurveysPrimary· 12 weeks
Participants completed EMA surveys (5x/day for 14 days). At each prompt they were asked if an eating episode occurred. If they indicated 'yes', they were asked to check all that apply: a) I ate past the point of feeling full, b) I ate more than usual, c) I had unplanned eating (i.e., consumed food when I don't usually eat and was not making up for a missed meal, or d) None of the above. If the participant responded with a, b, or c, it was classified as an 'overeating episode'. Further, at each prompt, participants were asked to the respond to the following: 'Right now I feel stressed' (1=not a
Group
Value
95% CI
Exercise Condition
0.74
± 1.56
Delayed Exercise Condition
0.55
± 1.0
Percentage of Overeating Episodes Characterized as 'Overeating'Primary· 12 weeks
If an eating episode occurred, participants were asked to check all that apply: a) I ate past the point of feeling full, b) I ate more than usual, c) I had unplanned eating (i.e., consumed food when I don't usually eat and was not making up for a missed meal, or d) None of the above. If response was a, b, or c, it was classified as an 'overeating episode'.
Group
Value
95% CI
Exercise Condition
21.98
± 3.32
Delayed Exercise Condition
26.62
± 3.58
Change in Body Weight (% Initial Weight)Secondary· baseline and 12 weeks
Percent weight change from baseline to 12 weeks
Group
Value
95% CI
Exercise Condition
-1.1
± 3.5
Delayed Exercise Condition
0.4
± 2.0
Stress as Measured Via QuestionnaireSecondary· Baseline and 12 weeks
The 10-item Perceived Stress Scale (Cohen 1988) was used to assess changes in stress by treatment arm from baseline to 12 weeks. Scores on this measure range from 0-40 with a higher score indicating greater perceived stress. Presented values are 12 week scores adjusted for baseline values.
Group
Value
95% CI
Exercise Condition
22.7
± 0.8
Delayed Exercise Condition
21.5
± 0.8
Sponsor's own description
The purpose of this study is to examine the psychological benefits of chronic exercise as well as the effects of exercise training on eating behaviors and stress-induced overeating in overweight and obese women. Participants will be randomized to an 12-week exercise condition or a delayed exercise condition. Assessments will occur at baseline, 6 weeks, and 12 weeks and will include answering surveys in real-time using smartphones, several assessments of eating behaviors and dietary intake, and questionnaire measures of factors which could mediate the relationship between exercise and eating. Participants will be compensated for completing assessments and for adherence to the exercise protocol.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07059884 — Distance-Based Exercise to Preserve Function and Prevent Disability
· NA
· recruiting
NCT07271082 — Efficacy and Safety of Home-based Structured Physical Exercise in Patients With Acute Ischemic Stroke
· NA
· recruiting
NCT06962579 — The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy
· NA
· recruiting
NCT06785324 — Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
· NA
· recruiting
NCT06931210 — Study of AI-based Prediction Models for Exercise-Induced Gut Microbiota Alterations in Patients With Type 2 Diabetes
· NA
· completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
NCT07403604 — Effect of Insulin Lowering on Lipogenesis
· Phase 1
· recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee
· Phase 3
· recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass
· recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart
· Phase 3
· recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl
· Phase 1
· recruiting
Other The Miriam Hospital trials
Trials by the same sponsor.
NCT07228130 — Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
· NA
· recruiting
NCT07363616 — Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight
· NA
· recruiting
NCT06494488 — Differential Thrombogenesis by EPA and DHA Mediated by HDL
· EARLY_PHASE1
· recruiting
NCT06878872 — Type 1 Diabetes Adolescents for Healthier Lifestyles Study
· NA
· not yet recruiting
NCT06875622 — Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial)
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Miriam Hospital
Last refreshed: 29 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02936076.